134 related articles for article (PubMed ID: 11853020)
1. Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
Calon F; Birdi S; Rajput AH; Hornykiewicz O; Bédard PJ; Di Paolo T
J Neuropathol Exp Neurol; 2002 Feb; 61(2):186-96. PubMed ID: 11853020
[TBL] [Abstract][Full Text] [Related]
2. Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
Mov Disord; 2006 Jan; 21(1):9-17. PubMed ID: 16127720
[TBL] [Abstract][Full Text] [Related]
3. Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.
Morissette M; Goulet M; Soghomonian JJ; Blanchet PJ; Calon F; Bédard PJ; Di Paolo T
Brain Res Mol Brain Res; 1997 Oct; 49(1-2):55-62. PubMed ID: 9387863
[TBL] [Abstract][Full Text] [Related]
4. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease.
Henry B; Duty S; Fox SH; Crossman AR; Brotchie JM
Exp Neurol; 2003 Oct; 183(2):458-68. PubMed ID: 14552886
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
Cheshire P; Ayton S; Bertram KL; Ling H; Li A; McLean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR
Mov Disord; 2015 May; 30(6):796-804. PubMed ID: 25649148
[TBL] [Abstract][Full Text] [Related]
6. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
Herrero MT; Augood SJ; Hirsch EC; Javoy-Agid F; Luquin MR; Agid Y; Obeso JA; Emson PC
Neuroscience; 1995 Oct; 68(4):1189-98. PubMed ID: 8544992
[TBL] [Abstract][Full Text] [Related]
7. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
[TBL] [Abstract][Full Text] [Related]
8. Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
Calon F; Rajput AH; Hornykiewicz O; Bédard PJ; Di Paolo T
Neurobiol Dis; 2003 Dec; 14(3):404-16. PubMed ID: 14678757
[TBL] [Abstract][Full Text] [Related]
9. Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Aubert I; Guigoni C; Li Q; Dovero S; Bioulac BH; Gross CE; Crossman AR; Bloch B; Bezard E
Biol Psychiatry; 2007 Apr; 61(7):836-44. PubMed ID: 16950226
[TBL] [Abstract][Full Text] [Related]
10. Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
Calon F; Morissette M; Rajput AH; Hornykiewicz O; Bédard PJ; Di Paolo T
Mov Disord; 2003 Mar; 18(3):241-253. PubMed ID: 12621627
[TBL] [Abstract][Full Text] [Related]
11. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
Tamim MK; Samadi P; Morissette M; Grégoire L; Ouattara B; Lévesque D; Rouillard C; Di Paolo T
Neuropharmacology; 2010 Jan; 58(1):286-96. PubMed ID: 19576910
[TBL] [Abstract][Full Text] [Related]
12. Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats.
Sgroi S; Capper-Loup C; Paganetti P; Kaelin-Lang A
Exp Neurol; 2016 Jun; 280():80-8. PubMed ID: 27072528
[TBL] [Abstract][Full Text] [Related]
13. Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions.
Pirker W; Tedroff J; Pontén H; Gunne L; Andrén PE; Hurd YL
Exp Neurol; 2001 May; 169(1):122-34. PubMed ID: 11312565
[TBL] [Abstract][Full Text] [Related]
14. Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?
Sancesario G; Morrone LA; D'Angelo V; Castelli V; Ferrazzoli D; Sica F; Martorana A; Sorge R; Cavaliere F; Bernardi G; Giorgi M
Neurochem Int; 2014 Dec; 79():44-56. PubMed ID: 25452081
[TBL] [Abstract][Full Text] [Related]
15. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
de la Fuente-Fernández R; Sossi V; Huang Z; Furtado S; Lu JQ; Calne DB; Ruth TJ; Stoessl AJ
Brain; 2004 Dec; 127(Pt 12):2747-54. PubMed ID: 15329355
[TBL] [Abstract][Full Text] [Related]
16. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
[TBL] [Abstract][Full Text] [Related]
17. Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
Nisbet AP; Foster OJ; Kingsbury A; Eve DJ; Daniel SE; Marsden CD; Lees AJ
Neuroscience; 1995 May; 66(2):361-76. PubMed ID: 7477878
[TBL] [Abstract][Full Text] [Related]
18. Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey.
Quik M; Police S; Langston JW; Di Monte DA
Neuroscience; 2002; 113(1):213-20. PubMed ID: 12123699
[TBL] [Abstract][Full Text] [Related]
19. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
Calon F; Dridi M; Hornykiewicz O; Bédard PJ; Rajput AH; Di Paolo T
Brain; 2004 May; 127(Pt 5):1075-84. PubMed ID: 15033896
[TBL] [Abstract][Full Text] [Related]
20. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias.
Piccini P; Weeks RA; Brooks DJ
Ann Neurol; 1997 Nov; 42(5):720-6. PubMed ID: 9392571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]